Please login to the form below

Not currently logged in

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Roche - Basel, Switzerland

Drug originally approved as a lymphoma treatment

Biogen loses another pipeline drug to toxicity concerns

BiogenFollows discontinuation of Eisai-partnered Alzheimer's drug

FDA starts speedy review of Merck’s Ebola vaccine

First company to file for approval in the US

Purdue Pharma files for bankruptcy after opioid settlement

purdue pharma logoCompany has faced brunt of blame for fuelling epidemic

Novartis eyes potential new indication for Cosentyx

Novartis HQUnveils positive late-stage results in axial spondyloarthritis

Acceleron scraps rare muscular dystrophy drug

AcceleronClinical profile not strong enough to push into late-stage testing

J&J's Tremfya filed for approval in US for psoriatic arthritis

Seeking share of increasingly competitive psoriasis market

New data backs GeNeuro’s MS drug after Servier exit

Brain scanSearch continues for new development partner

Envision Pharma Group relocates to support expansion

EPG logoOffice moves in the US prompted by significant growth

Jessica Pacey 2Q&A: Jessica Pacey

PME interviews the founder and chief executive of newly launched health comms agency, 67health

Featured jobs

Subscribe to our email news alerts


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Detecting Alzheimer’s ahead of a cure
A focus on promising new research...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Can you survive without the blue dot?
Or has the digital world has replaced our brain...